Nucleic acid-sensing receptors are crucial for initiating protective immune responses against viruses, but aberrant activation of these receptors can also drive pathological inflammation. In this Review, the authors discuss the new agonists and antagonists that are being developed to target these receptors in the clinic.
- Tobias Junt
- Winfried Barchet